Taiwan FDA registration dbc07661c21cb6b10dd2a888cb5e5131
"Elifoss" residual antibiotic active reagent (unsterilized)
TW: "艾利福斯" 殘留抗生素活性試劑 (未滅菌)
Taiwan·Risk Class 1·Alifax S.r.l.·Registered Jul 10, 2019 – Jul 10, 2024ExpiredRegistration details
- Analysis ID
- dbc07661c21cb6b10dd2a888cb5e5131
- Customs Code
- DHA09402063400
Company information
- Manufacturer
- Alifax S.r.l.
- Manufacturer Country
- Italy
- Authorized Representative
- GRAND MARQUIS CO., LTD.
Product details
- Intended Use
- This product is limited to urine samples to detect antibiotic residues in urine. This product is only available for ALIFAX microbial analyzers.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.9999 Miscellaneous
- Import Information
- Input;; QMS/QSD
Dates and status
- Registration Date
- Jul 10, 2019
- Expiry Date
- Jul 10, 2024
About this record
Access comprehensive regulatory information for "Elifoss" residual antibiotic active reagent (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number dbc07661c21cb6b10dd2a888cb5e5131 and manufactured by Alifax S.r.l.. The authorized representative in Taiwan is GRAND MARQUIS CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices